ESTROGENS FOR WOMEN - THE RISK BENEFIT RATIO

被引:0
|
作者
MCKENNA, TJ
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:219 / 221
页数:3
相关论文
共 50 条
  • [41] Risk:benefit ratio is important in treating atopic dermatitis
    Allen, BR
    Luger, TA
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7370): : 970 - 970
  • [42] ENALAPRIL - BENEFIT-TO-RISK RATIO IN HYPERTENSIVE PATIENTS
    GOMEZ, HJ
    CIRILLO, VJ
    SMITH, SG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 : S26 - S29
  • [43] PHARMACOVIGILANCE - ESTIMATION OF THE RATIO BENEFIT RISK IN CURRENT PRACTICE
    DEMAREZ, JP
    COUZINIER, JP
    BEGAUD, B
    THERAPIE, 1985, 40 (05): : 333 - 335
  • [44] Diane (R) 35, an unfavorable risk/benefit ratio
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2013, 52 (524): : 6 - 6
  • [45] Androgenic alopecia; the risk-benefit ratio of Finasteride
    Rowland, David L.
    Motofei, Ion G.
    Paunica, Ioana
    Banu, Petrisor
    Nistor, Mihaela F.
    Paunica, Stana
    Constantin, Vlad D.
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2018, 5 (01): : 1 - 6
  • [46] THIAZIDES - THE TRUE BENEFIT-RISK RATIO - REPLY
    FREIS, ED
    HOSPITAL PRACTICE, 1990, 25 (10A): : 19 - &
  • [48] RISK-BENEFIT RATIO IN ARTERIAL-SURGERY
    SIMEONE, FA
    AMERICAN JOURNAL OF SURGERY, 1984, 148 (03): : 299 - 300
  • [49] The risk:benefit ratio of using antidepressants during pregnancy
    Steiner, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S177 - S178
  • [50] Review of clinical trials and benefit/risk ratio of meloxicam
    Barner, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 29 - 37